| Name | Flurocitabine |
|---|---|
| Synonyms |
Fluorocitabin
AAFC (2R)-7-Fluoro-2,3,3aβ,9aβ-tetrahydro-3β-hydroxy-6-imino-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2α-methanol 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 7-fluoro-2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, (2R,3R,3aS,9) NSC-166641 5-fluoro-arabino-O2,O2'-cyclocytidine 5-Fluor-2,2'-cyclocytidin (2R,3R,3aS,9-7-Fluoro-2,3,3a,9a-tetrahydro-3-hydroxy-6-iMino-6H-furo(2',3':4,5)oxazolo(3,2-a)pyriMidine-2-Methanol Ro-21-0702 fluoroancitabine 5-fluoro-arabino-2,2'-anhydro-cytidine 5-Fluoro-2,2'-cyclocytidine |
| Description | Flurocitabine is a fluorinated anlydride analog of cytosine arabinoside, partially hydrolysecl in vivo into two active antitumor substances (arabinosyl-tluorocytosine (ara-FC) and arabinosyl-fluorouracil (ara-FU)). Flurocitabine has antitumor activity during phase I studies in acute leukemia and solid tumors[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 2.11g/cm3 |
|---|---|
| Boiling Point | 391.7ºC at 760mmHg |
| Molecular Formula | C9H10FN3O4 |
| Molecular Weight | 243.19200 |
| Flash Point | 190.7ºC |
| Exact Mass | 243.06600 |
| PSA | 100.59000 |
| Index of Refraction | 1.813 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|